Related Experiment Videos
Anterior spinal artery syndrome
H Baba1, K Tomita, T Kawagishi
1Department of Orthopaedic Surgery, Fukui Medical School, Japan.
International Orthopaedics
|December 1, 1993
Summary
Direct perfusion of dexamethasone sodium phosphate and urokinase into the artery of Adamkiewicz effectively treated anterior spinal artery syndrome. Patients with paraparesis and sensory loss experienced significant recovery after this interventional therapy.
Area of Science:
- Neurology
- Vascular Surgery
- Interventional Radiology
Background:
- Anterior spinal artery syndrome presents with significant neurological deficits, including paraparesis, sensory loss, and sphincter dysfunction.
- The etiology of anterior spinal artery syndrome can be diverse, often presenting without clear causative factors.
- Effective treatment strategies for acute anterior spinal artery syndrome remain a critical area of clinical research.
Observation:
- Three patients presenting with acute anterior spinal artery syndrome underwent direct arterial perfusion therapy.
- The treatment involved targeted delivery of dexamethasone sodium phosphate and urokinase into the artery of Adamkiewicz.
- Therapeutic interventions were administered in three consecutive sessions, spaced one week apart, during the early disease phase.
Findings:
- All three patients demonstrated a positive clinical response to the direct perfusion therapy.
- Significant improvement in neurological symptoms, including motor function, sensory perception, and sphincter control, was observed.
- The treatment approach was well-tolerated, with no immediate adverse events reported.
Implications:
- Direct arterial perfusion of dexamethasone and urokinase represents a promising therapeutic option for anterior spinal artery syndrome.
- This interventional strategy may offer a pathway to improved recovery outcomes in patients with this condition.
- Further research is warranted to validate these findings and establish standardized treatment protocols.